AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet
Clicks: 215
ID: 269770
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
209 views
54 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (18 words).
Try re-searching for a better abstract.
| Reference Key |
hj2018intensiveaki
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | de Grooth HJ;Parienti JJ;Schetz M;; |
| Journal | intensive care medicine |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
pubmed abstract
nih
national institutes of health
national library of medicine
biomarkers*
comment
editorial
pmid:29651499
doi:10.1007/s00134-018-5151-7
harm-jan de grooth
jean-jacques parienti
miet schetz
acute kidney injury
renal replacement therapy*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.